Abstract
In the treatment of posttraumatic stress disorder (PTSD) – the most clinically relevant trauma sequelae in literature and clinical practice – psychopharmacotherapy has a subordinate role compared to psychotherapeutic procedures. Compared to the relatively large number of publications on posttraumatic disorders and their psychotherapeutic treatment, there are comparatively few studies on the therapeutic use of psychotropic substances. According to the current state of knowledge, psychopharmacotherapy nevertheless represents a useful addition to the overall treatment plan of posttraumatic disorders, which is indicated in particular for severe PTSD syndromes with hyperexcitability, panic attacks and depressive symptoms, if possible in combination with psychotherapy. First choice drugs for posttraumatic stress disorder are antidepressants from the SSRI group (e.g. sertraline, paroxetine) or pharmacologically similar substances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literature
Ahearn, E. P., Juergens, T., Cordes, T., Becker, T., & Krahn, D. (2011). A review of atypical antipsychotic medications for posttraumatic stress disorder. International Clinical Psychopharmacology, 26(4), 193–200.
Amos, T., Stein, D. J., & Ipser, J. C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTBS). Cochrane Database of Systematic Reviews, 8, CD006239.
APA (American Psychiatric Association). (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). American Psychiatric Association.
Asnis, G. M., Kohn, S. R., Henderson, M., & Brown, N. L. (2004). SSRIs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs, 64(4), 383–404.
Baker, D. G., Diamond, B. I., Gillette, G., Hamner, M., Katzelnick, D., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., & Tucker, P. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386–389.
Bauer, M., & Berghöfer, A. (1997). Leitlinien und praktische Durchführung der Pharmakotherapie mit Antidepressiva. In M. Bauer & A. Berghöfer (Eds.), Therapieresistente Depressionen. Springer.
Bauer, M., Pfennig, A., Severus, E., et al. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. World Journal of Biological Psychiatry, 14, 334–385.
Bauer, M., Severus, E., Köhler, S., et al. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: Maintenance treatment of major depressive disorder-update 2015. World Journal of Biological Psychiatry, 16, 76–95.
Becker, M. E., Hertzberg, M. A., Moore, S. D., Dennis, M. F., Bukenya, D. S., & Beckham, J. C. (2007). A placebocontrolled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 27, 193–197.
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 169–180.
Berlin, H. A. (2007). Antiepileptic drugs for the treatment of post-traumatic stress disorder. Current Psychiatry Reports, 9, 291–300.
Bonne, O., Grillon, C., Vythilingam, M., Neumeister, A., & Charney, D. S. (2004). Adaptive and maladaptive psychobiological responses to severe psychological stress: Implications for the discovery of novel pharmacotherapy. Neuroscience of Biobehavioral Reviews, 28(1), 65–94.
Brady, K. T., Killeen, T. K., Brewerton, T., & Lucerini, S. (2000). Comorbidity of psychiatric disorders and posttraumatic stress disorder. Journal of Clinical Psychiatry, 61(suppl. 7), 22–32.
Braun, P., Greenberg, D., Dasberg, H., & Lerer, B. (1990). Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry, 51, 236–238.
Carey, P., Suliman, S., Ganesan, K., Seedat, S., & Stein, D. J. (2012). Olanzapine monotherapy in posttraumatic stress disorder: Efficacy in a randomized, double-blind, placebo-controlled study. Human Psychopharmacology, 27, 386–391.
Charney, D. S., Deutch, A. Y., Krystal, J. H., Southwick, S. M., & Davis, M. (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry, 50, 294–305.
Cipriani, A., Williams, T., Nikolakopoulou, A., et al. (2017). Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: A network meta-analysis. Psychological Medicine, 19, 1–10.
Davidson, J. (1992). Drug therapy of post-traumatic stress disorder. British Journal of Psychiatry, 160, 309–314.
Davidson, J. (2006). Pharmacologic treatment of acute and chronic stress following trauma. Journal of Clinical Psychiatry, 67(suppl 2), 34–39.
Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., Saunders, W. B., & Cavenar, J. O. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259–266.
Ebbinghaus, R., Bauer, M., & Priebe, S. (1996). Behandlung der posttraumatischen Belastungsstörung. Eine Übersicht. Fortschritte der Neurologie, Psychiatrie, 64, 433–443.
Foa, E. B., Davidson, J. R. T., & Frances, A. (1999). The expert consensus guidelines series: Treatment of posttraumatic stress disorder. Journal of Clinical Psychiatry, 60(suppl. 16), 1–76.
Friedman, M. J. (1988). Toward rational pharmacotherapy for posttraumatic stress disorder: An interim report. American Journal of Psychiatry, 145, 281–285.
Gelpin, E., Bonne, O., Peri, T., Brandes, D., & Shalev, A. Y. (1996). Treatment of recent trauma survivors with benzodiazepines: A prospective study. Journal of Clinical Psychiatry, 57, 390–394.
Gersons, B. P. R., & Denis, D. (1996). Das Konzept der posttraumatischen Belastungsstörung. In S. Priebe, D. Denis, & M. Bauer (Eds.), Eingesperrt und nie mehr frei. Psychisches Leiden nach politischer Haft in der DDR. Steinkopff.
Giourou, E., Skokou, M., Andrew, S. P., Alexopoulou, K., Gourzis, P., & Jelastopulu, E. (2018). Complex posttraumatic stress disorder: The need to consolidate a distinct clinical syndrome or to reevaluate features of psychiatric disorders following interpersonal trauma? World Journal of Psychiatry, 22, 12–19.
Hageman, I., Andersen, H. S., & Jorgensen, M. B. (2001). Post-traumatic stress disorder: A review of psychobiology and pharmacotherapy. Acta Psychiatrica Scandinavica, 104, 411–422.
Hollweg, M., & Soyka, M. (1996). Benzodiazepine – Indikationen, unerwünschte Arzneimittelwirkungen und Risiken bei Langzeitbehandlung. Psychopharmakotherapie, 4, 161–167.
Hoskins, M., Pearche, J., Bethell, A., et al. (2015). Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis. British Journal of Psychiatry, 206, 93–100.
Ipser, J. C., & Stein, D. J. (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTBS). International Journal of Neuropsychopharmacology, 15, 825–840.
Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J., & Giller, E. L. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366–370.
Maercker, A., & Augsburger, M. (2017). Psychotraumatologie. Nervenarzt, 88, 967–973.
Müller-Oerlinghausen, B., Berghöfer, A., & Bauer, M. (2002). Bipolar disorder. Lancet, 359, 241–224.
Neal, L. A., Shapland, W., & Fox, C. (1997). An open trial of moclobemide in the treatment of post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 231–237.
Nobles, C. J., Valentine, S. E., & Zepeda, E. D. (2017). Usual course of treatment and predictors of treatment utilization for patients with posttraumatic stress disorder. Journal of Clinical Psychiatry, 78(suppl. 5), e559–e566.
Pae, C. U., Lim, H. K., Peindl, K., Ajwani, N., Serretti, A., Patkar, A. A., & Lee, C. (2008). The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Clinical Psychopharmacology, 23(1), 1–8.
Post, R. M., & Weiss, S. R. B. (1989). Sensitization, kindling, and anticonvulsants in mania. Journal of Clinical Psychiatry, 50(suppl. 12), 23–30.
Raskind, M. A., Peskind, E. R., Chow, B., et al. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. The New England Journal of Medicine, 378, 507–517.
Reist, C., Kauffmann, C. D., Haier, R. J., Sangdahl, C., DeMet, E. M., Chicz-DeMet, A., & Nelson, J. N. (1989). A controlled trial of desipramine in 18 men with posttraumatic stress disorder. American Journal of Psychiatry, 146, 513–516.
Shestatzky, M., Greenberg, D., & Lerer, B. (1988). A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Research, 24, 149–155.
Shiner, B., Westgate, C. L., Bernardy, N. C., et al. (2017). Anticonvulsant medication use in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry, 78, e545–e552.
Sijbrandij, M., Kleiboer, A., Bisson, J. I., Barbui, C., & Cuijpers, P. (2015). Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: A systematic review and meta-analysis. Lancet Psychiatry, 2, 413–421.
Steckler, T., & Risbrough, V. (2012). Pharmacological treatment of PTBS – Established and new approaches. Neuropharmacology, 62, 617–627.
Stein, D. J., Ipser, J. C., & Seedat, S. (2006). Pharmacotherapy for post traumatic stress disorder (PTBS). Cochrane Database of Systematic Reviews, (1), CD002795. https://doi.org/10.1002/14651858.CD002795.pub2
van der Kolk, B. A., & Greenberg, M. S. (1987). The psychobiology of the trauma response: Hyperarousal, constriction, and addiction to traumatic reexposure. In B. A. van der Kolk Psychological trauma. : American Psychiatric Press.
van Zuiden, M., Frijling, J. L., Nawijn, L., Koch, S. B. J., Goslings, J. C., Luitse, J. S., Biesheuvel, T. H., Honig, A., Veltman, D. J., & Olff, M. (2017). Intranasal oxytocin to prevent posttraumatic stress disorder symptoms: A randomized controlled trial in emergency department patients. Biological Psychiatry, 81, 1030–1040.
Villarreal, G., Mamner, M. B., Cañive, J. M., et al. (2016). Efficacy of quetiapine monotherapy in posttraumatic stress disorder: A randomized, placebo-controlled trial. American Journal of Psychiatry, 173, 1205–1212.
Watts, B. V., Schnurr, P. P., Mayo, L., et al. (2013). Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. Journal of Clinical Psychiatry, 74(suppl. 6), e541–e550.
WHO (World Health Organization). (2013). Guidelines for the management of conditions specifically related to stress. World Health Organization.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer-Verlag GmbH, DE, part of Springer Nature
About this chapter
Cite this chapter
Bauer, M., Priebe, S., Severus, E. (2022). Psychopharmacotherapy of Trauma Sequelae. In: Maercker, A. (eds) Trauma Sequelae. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64057-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-662-64057-9_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64059-3
Online ISBN: 978-3-662-64057-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)